Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders

NCT07727356 is registered in ClinicalTrials.gov with Felix Beuschlein as lead sponsor.

NCT NCT07727356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07727356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EndoSense: Continuous Real-Time Monitoring of Health Markers in Endocrine and Metabolic Disorders
Lead sponsor
Felix Beuschlein
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 3, 2026
Completion date
August 31, 2036
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cortisol excess, endocrine disorders, healthy adult, hypertension, obesity & overweight, primary aldosteronism